68 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M Downtrend
Article Searches
Here's Why Pacific Biosciences of California Is Surging Today https://www.fool.com/investing/2017/08/03/heres-why-pacific-biosciences-of-california-is-sur.aspx?source=iedfolrf0000001 Aug 03, 2017 - The sequencing company topped off a solid second-quarter earnings report with news of a big order from its best customer.
Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales https://www.fool.com/investing/2017/08/03/pacific-biosciences-of-california-struggles-in-sec.aspx?source=iedfolrf0000001 Aug 03, 2017 - The genetic-sequencing company's lone bright spot was higher product sales, but it wasn't enough to offset the loss of contract revenue.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4094051-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q2-2017-results-earnings-call?source=feed_sector_healthcare Aug 03, 2017 - Pacific Biosciences of California (NASDAQ:PACB) Q2 2017 Earnings Conference Call August 2, 2017 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP of Finan
Trellus Management Company, LLC Buys Uniti Group Inc, ShotSpotter Inc, General Electric Co, ... http://www.gurufocus.com/news/545177/trellus-management-company-llc-buys-uniti-group-inc-shotspotter-inc-general-electric-co-sells-jinkosolar-holding-co-mazor-robotics-viasat-inc Jul 25, 2017 - Trellus Management Company, LLC Buys Uniti Group Inc, ShotSpotter Inc, General Electric Co, Sells JinkoSolar Holding Co, Mazor Robotics, Viasat Inc, Stocks: PACB,SGYP,NBR,QDEL,CHKE,CSIQ,UNIT,SSTI,GE,AAXN,POT, release date:Jul 25, 2017
Pacific Biosciences (PACB) Prices Offering of Common Stock http://www.zacks.com/stock/news/264515/pacific-biosciences-pacb-prices-offering-of-common-stock?cid=CS-ZC-FT-264515 Jun 16, 2017 - Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.
This Is the Big Reason Behind Pacific Biosciences of California, Inc.'s 24% Tumble in April https://www.fool.com/investing/2017/05/03/this-is-the-big-reason-behind-pacific-biosciences.aspx?source=iedfolrf0000001 May 03, 2017 - Despite topping Q1 revenue estimates, another figure in Pacific Biosciences quarterly report doomed its stock.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4066331-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2017-results-earnings-call?source=feed_sector_healthcare Apr 27, 2017 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2017 Results Earnings Conference Call April 26, 2017 4:30 p.m. ET Executives Trevin Rard - IR Mike Hunkapiller - Chief Executive Officer Susan
Pacific Biosciences of California Reports Q1 Loss Due to Higher Costs https://www.fool.com/investing/2017/04/27/pacific-biosciences-of-california-reports-q1-loss.aspx?source=iedfolrf0000001 Apr 27, 2017 - The genetic-sequencing company increased revenue, but still wound up with a wider loss.
Here's Why Pacific Biosciences of California Is Sliding Today https://www.fool.com/investing/2017/04/27/heres-why-pacific-biosciences-of-california-is-sli.aspx?source=iedfolrf0000001 Apr 27, 2017 - Mixed first-quarter results near the top line led to a wider-than-expected first-quarter loss on the bottom line.
Pacific Biosciences (PACB) Q1 Loss Wider than Estimated http://www.zacks.com/stock/news/258121/pacific-biosciences-pacb-q1-loss-wider-than-estimated?cid=CS-ZC-FT-258121 Apr 27, 2017 - Pacific Biosciences of California Inc. (PACB) reported a loss of 26 cents per share in the first quarter of 2017. The figure is 3 cents wider than the Zacks Consensus Estimate.

Pages: 1234567

<<<Page 5>